Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from BICO Group AB Class B ( (SE:BICO) ) is now available.
BICO Group AB has announced the appointment of Ewa Linsäter as the new Chief Financial Officer, succeeding Jacob Thordenberg. Linsäter brings over 15 years of experience in financial leadership roles, including her recent position at Elos Medtech. Her expertise in international life science and mergers and acquisitions is expected to contribute significantly to BICO’s strategic ambitions in lab automation and life science solutions. This leadership transition is poised to strengthen BICO’s financial position and support its continued development in the industry.
The most recent analyst rating on (SE:BICO) stock is a Hold with a SEK20.50 price target. To see the full list of analyst forecasts on BICO Group AB Class B stock, see the SE:BICO Stock Forecast page.
More about BICO Group AB Class B
BICO Group AB is a lab automation partner and provider of selected workflows to the pharmaceutical and biotech industries. With over 48,000 instruments installed in more than 65 countries, BICO’s products, software, and solutions are utilized in over 3,500 laboratories, including the world’s top 20 pharmaceutical companies. The company operates through two main business areas: Lab Automation and Life Science Solutions, aiming to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under the ticker BICO.
Average Trading Volume: 238,377
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.4B
See more data about BICO stock on TipRanks’ Stock Analysis page.